Health insurers’ use of AI tools linked to soaring claim denials: The claim denials process has become maddening for patients and providers alike.
Most healthcare AI startups want to sell their solutions to health systems: But these tech companies struggle to demonstrate their value prop to potential healthcare provider buyers.
Each patient generation takes a unique path on their health journey: We unpack the channels where patients begin their health journeys and explore how marketers can tailor their engagement strategies to best reach each generation.
Noom gets into compounded GLP-1s with a taper-off guarantee: It’s building a weight loss program around the idea that patients will eventually want to stop taking the medications. We explore the pros and cons.
FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.
The Surgeon General’s plan to protect kids, backed by state attorneys general, could change how platforms and advertisers engage users.
Apple unveils new Apple Watch feature that detects sleep apnea: The timing of the feature’s unveiling could be the spark Apple needs to reignite its stagnating device business.
AI chatbots help busy healthcare providers communicate with patients: Consumers would rather engage with AI than wait on hold for a human. But many are concerned with the tech’s reliability and ability to protect their data.
Biden Administration’s final rules aim to boost mental healthcare parity law: But with no new enforcement mechanisms in place, we’re bearish on their ability to improve patients’ access to mental healthcare in a meaningful way.
Global consumers are investing money to improve their health: There’s a market opportunity for brands and retailers across multiple sectors to reach consumers’ wallets via social media.
Ochsner expands its virtual weight management solution: The health system’s focus on selectively prescribing GLP-1s through affiliated physicians is a discerning financial move.
Senior-focused primary care orgs get patients to have more visits: While interesting, new findings from the Humana-led study should be taken with a grain of salt. The insurer has skin in the game with its CenterWell Senior Primary Care brand and clinics.
On today's podcast episode, we discuss how physicians are thinking about AI, the specific problems in healthcare that AI is trying to solve, and what it should never be used for in the space. Tune in to the discussion with host Marcus Johnson and analyst Rajiv Leventhal.
Vitamin Shoppe, Marius Pharma sell testosterone replacement therapy: The tie-up should help the supplement retailer acquire customers and the drugmaker get its treatment to more patients.
NYU Langone Health rolls out walk-in primary care: We think it’s a smart patient acquisition play by the health system. Here's why.
Marketers use AI, social media to engage with physicians: Marketers who don’t shift their advertising resources to match doctors’ evolving media consumption habits will fall behind.
The US healthcare system is failing women: Other high-income countries provide better access to affordable care. US brands and marketers can address system-wide failures by better connecting with female patients.
OMNY Health launches GLP-1 data network: We think that structured GLP-1 data could benefit precision medicine efforts.
GenAI tops pharma and health marketers’ list of consumer trends to watch: We’ll be keeping a close eye on whether growing consumer distrust of the tech actually drives adoption down.
New data raises concern about FDA-cleared AI medical devices: Many devices received the FDA stamp without clinical validation. We unpack why FDA approval alone won’t be enough to secure buy-in from end-user clinicians.